Subtopic Deep Dive

← Phenothiazines and Benzothiazines Synthesis and Activities

Phenothiazine Anticancer Mechanisms
Research Guide

What is Phenothiazine Anticancer Mechanisms?

Phenothiazine anticancer mechanisms involve FDA-approved phenothiazines inducing apoptosis, autophagy, and ROS-mediated cytotoxicity selectively in cancer cells through pathways like PP2A activation and efflux pump inhibition.

Research demonstrates phenothiazines such as thioridazine suppress proliferation in leukemic cells without harming normal lymphocytes (Zhelev et al., 2004, 137 citations). Gutiérrez et al. (2014, 219 citations) identified phenothiazines inducing PP2A-mediated apoptosis in T-ALL via high-throughput screens. Over 10 key papers from 2003-2023 explore structure-activity relationships and in vivo efficacy in models like mouse skin carcinogenesis (Azuine et al., 2003, 120 citations).

Curated Papers

Key Challenges

Why It Matters

Phenothiazine repurposing provides cost-effective anticancer agents with established safety profiles for clinical translation, as shown in T-ALL screens (Gutiérrez et al., 2014). They selectively kill cancer cells like neuroblastoma and glioma via apoptosis without affecting normal cells (Gil-Ad et al., 2004; Zhelev et al., 2004). Applications include combination therapies overcoming drug resistance and chemoprevention in two-stage carcinogenesis models (Azuine et al., 2003; Wu et al., 2016). Varga et al. (2017) highlight multi-target effects on dopamine receptors and efflux pumps for broad tumor applicability.

Key Research Challenges

Selectivity for Cancer Cells

Phenothiazines must induce apoptosis in tumor cells without toxicity to normal lymphocytes, as demonstrated in leukemic models (Zhelev et al., 2004). Achieving therapeutic windows remains difficult due to off-target receptor binding (Varga et al., 2017).

Elucidating Molecular Pathways

Mechanisms like PP2A activation in T-ALL require detailed pathway mapping beyond initial screens (Gutiérrez et al., 2014). Integrating ROS, autophagy, and efflux inhibition needs multi-omics validation (Wu et al., 2016).

In Vivo Efficacy Translation

Promising in vitro results in glioma and neuroblastoma face barriers in animal models and clinical trials (Gil-Ad et al., 2004). Optimizing pharmacokinetics for tumor penetration is critical (Al Zahrani et al., 2020).

Essential Papers

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia

Alejandro Gutiérrez, Pan Li, Richard W.J. Groen et al. · 2014 · Journal of Clinical Investigation · 219 citations

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer that is frequently associated with activating mutations in NOTCH1 and dysregulation of MYC. Here, we performed 2 complementary sc...

Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria

Yiannis C. Fiamegos, Panagiotis L. Kastritis, Vassiliki Exarchou et al. · 2011 · PLoS ONE · 182 citations

These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior i...

Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes

Zhivko Zhelev, Hideki Ohba, Rumiana Bakalova et al. · 2004 · Cancer Chemotherapy and Pharmacology · 137 citations

Possible Biological and Clinical Applications of Phenothiazines

Borisz Varga, Ákos Csonka, Andrea Csonka et al. · 2017 · Anticancer Research · 135 citations

Phenothiazines have been used in many areas of medicine, mainly in psychopharmacology. These compounds are able to effectively inhibit dopamine, histamine, serotonin, acetylcholine, and α-adrenergi...

Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models

Magnus A. Azuine, Harukuni Tokuda, Junko Takayasu et al. · 2003 · Pharmacological Research · 120 citations

Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action

Leonard Amaral, Miguel Viveiros · 2017 · Antibiotics · 99 citations

This review presents the evidence that supports the use of thioridazine (TZ) for the therapy of a pulmonary tuberculosis infection regardless of its antibiotic resistance status. The evidence consi...

Characterization of Phenothiazine-Induced Apoptosis in Neuroblastoma and Glioma Cell Lines: Clinical Relevance and Possible Application for Brain-Derived Tumors

Irit Gil‐Ad, Biana Shtaif, Yechiel Levkovitz et al. · 2004 · Journal of Molecular Neuroscience · 95 citations

Reading Guide

Foundational Papers

Start with Gutiérrez et al. (2014, 219 citations) for PP2A screening methodology in T-ALL; follow Zhelev et al. (2004, 137 citations) for selectivity proof in leukemia; Azuine et al. (2003, 120 citations) for in vivo chemoprevention.

Recent Advances

Wu et al. (2016, 87 citations) on repurposing strategy; Varga et al. (2017, 135 citations) on clinical applications; Al Zahrani et al. (2020, 91 citations) on chalcone hybrids.

Core Methods

High-throughput FDA drug screens (Gutiérrez 2014); apoptosis assays in cell lines (Zhelev 2004, Gil-Ad 2004); SAR synthesis (Al Zahrani 2020); mouse carcinogenesis (Azuine 2003).

How PapersFlow Helps You Research Phenothiazine Anticancer Mechanisms

Discover & Search

Research Agent uses searchPapers and citationGraph to map Gutiérrez et al. (2014, 219 citations) as central hub, revealing PP2A-apoptosis clusters; exaSearch uncovers related repurposing studies; findSimilarPapers expands to Zhelev et al. (2004) and Wu et al. (2016).

Analyze & Verify

Analysis Agent applies readPaperContent on Gutiérrez et al. (2014) abstracts for NOTCH1/MYC interactions, verifies claims via CoVe chain-of-verification, and runs PythonAnalysis on dose-response data from Zhelev et al. (2004) for IC50 stats with GRADE scoring evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in selectivity mechanisms between Zhelev (2004) and Gil-Ad (2004), flags contradictions in efflux roles; Writing Agent uses latexEditText, latexSyncCitations for Gutiérrez/Wu papers, and latexCompile for mechanism diagrams via exportMermaid.

Use Cases

"Analyze dose-response curves of phenothiazines in T-ALL from Gutiérrez 2014 and compute selectivity ratios vs normal cells."

Research Agent → searchPapers('Gutiérrez 2014 phenothiazine T-ALL') → Analysis Agent → readPaperContent + runPythonAnalysis(pandas/matplotlib on IC50 data) → statistical output with GRADE verification.

"Draft LaTeX review section on PP2A-mediated apoptosis mechanisms with citations."

Synthesis Agent → gap detection(Zhelev 2004, Gutiérrez 2014) → Writing Agent → latexEditText('apoptosis section') → latexSyncCitations → latexCompile → formatted PDF section.

"Find GitHub repos analyzing phenothiazine structure-activity data from Al Zahrani 2020."

Research Agent → paperExtractUrls('Al Zahrani 2020 chalcone phenothiazine') → paperFindGithubRepo → githubRepoInspect → code snippets for SAR modeling.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ phenothiazine papers: searchPapers → citationGraph(Gutiérrez hub) → structured report on apoptosis pathways. DeepScan applies 7-step analysis with CoVe checkpoints on Zhelev (2004) selectivity data. Theorizer generates hypotheses linking PP2A (Gutiérrez 2014) to ROS mechanisms in Wu (2016).

Try Doxa for Phenothiazine Anticancer Mechanisms Research

Frequently Asked Questions

What defines phenothiazine anticancer mechanisms?

Phenothiazines induce PP2A-mediated apoptosis in T-ALL (Gutiérrez et al., 2014) and suppress leukemic proliferation without harming normal cells (Zhelev et al., 2004).

What are key methods in this research?

High-throughput screens identify FDA-approved hits (Gutiérrez et al., 2014); cell line assays measure apoptosis in leukemia/glioma (Zhelev et al., 2004; Gil-Ad et al., 2004); mouse two-stage carcinogenesis tests chemoprevention (Azuine et al., 2003).

What are the most cited papers?

Gutiérrez et al. (2014, 219 citations) on PP2A-apoptosis; Zhelev et al. (2004, 137 citations) on selective leukemia killing; Azuine et al. (2003, 120 citations) on chemoprevention.

What open problems exist?

Translating in vitro selectivity to in vivo efficacy (Gil-Ad et al., 2004); resolving multi-pathway interactions like PP2A/ROS (Wu et al., 2016); optimizing SAR for brain tumors (Al Zahrani et al., 2020).